Vivanos Health
Vivanos Health is made and published by Vivanos Health, Inc. AppBrain is an independent app data site and isn't affiliated with Vivanos Health, Inc. The app name, icon, screenshots and description belong to Vivanos Health, Inc. and are shown as published on the App Store.
AppBrain's verdict
- Rating on App Store
- 5.00
- 1 ratings
- Last updated
- October 28, 2026
It doesn't have enough ratings yet to judge what users think.
Rankings
App Store top chartsApp Store Rankings for Vivanos Health
Competitors
Similar apps and more from Vivanos Health, Inc.Alternatives to Vivanos Health
Releases
Updates seen on the App Store- Version
- 2.0.0
- Launched
- December 2022
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Vivanos Health for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 44.3 MB
- Content rating
- High
Technologies used by Vivanos Health
About the app and developer
About Vivanos Health
Vivanos Health is a medical app developed by Vivanos Health, Inc.
User Ratings
Vivanos Health is rated 5.00 out of 5 stars. The rating is based on one rating ratings.
App Information
Vivanos Health is freely available from the App Store. The app size is 44.25 MB. The latest version available is 2.0.0. The last update was on October 28, 2026.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since December 2022.
Developer information for Vivanos Health, Inc.
Address:
Store listing
By Vivanos Health, Inc., from the App Store
Description by Vivanos Health, Inc. Written by the developer, not by AppBrain. Click to read.
Disclaimer
The use of this app is for informational purposes only and should not and cannot serve as a substitute for an examination and treatment by a qualified health care provider. Each person’s condition and situation is unique and individuals should consult a qualified health care provider for medical advice and answers to personal health questions. While this app attempts to be as accurate as possible, it should not be relied upon as being comprehensive or error-free.
Citations
Standards of Medical Care in Diabetes: Summary of Revisions.
DIABETES CARE 2022;45
https://diabetesjournals.org/care/article/45/Supplement_1/S4/138912/Summary-of-Revisions-Standards-of-Medical-Care-in
The Effect of Intensive Blood Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34).
LANCET 1998;352:854.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)07037-8/fulltext
Efficacy of Atenolol and Captopril in Reducing Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 39).
BR MED J 1998; 317:713.
https://pubmed.ncbi.nlm.nih.gov/9732338/
Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49).
JAMA 1999: 281:2005.
https://jamanetwork.com/journals/jama/fullarticle/190204
Intensive Blood Glucose Control with Sulfonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33).
Lancet 1998; 352:837.
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(98)07019-6.pdf
Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes (UKPDS 38).
BMJ 1998; 317:703.
https://pubmed.ncbi.nlm.nih.gov/9732337/
DCCT Research Group: The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.
N ENGL J MED 1993; 329:977.
https://www.nejm.org/doi/full/10.1056/nejm199309303291401